Demars Financial Group, LLC Organon & Co. Transaction History

Demars Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$31.66 - $38.9 $57,336 - $70,447	-1,811 Reduced 21.44%	6,636 $224,000
Q1 2022 Apr 27, 2022	SELL	$30.45 - $39.36 $304 - $393	-10 Reduced 0.12%	8,447 $295,000
Q4 2021 Feb 02, 2022	BUY	$28.67 - $37.13 $40,023 - $51,833	1,396 Added 19.77%	8,457 $258,000
Q3 2021 Oct 15, 2021	SELL	$28.63 - $35.64 $79,362 - $98,794	-2,772 Reduced 28.19%	7,061 $232,000
Q2 2021 Jul 16, 2021	BUY	$28.45 - $38.0 $279,748 - $373,654	9,833 New	9,833 $298,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Demars Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Demars Financial Group, LLC with notifications on news.